MedicalPriceCheck.com
|

Benralizumab 30 mg/ml Syringe Cost Comparison

J0517 (HCPCS)

Cash prices (without insurance) for Benralizumab 30 mg/ml Syringe (CPT J0517) range from $18,173 to $18,173 across 2 hospitals in 1 state. The national average cash price is $18,173.

Benralizumab is an injectable medication used to treat certain types of severe asthma. It may be prescribed for patients whose asthma is not well-controlled with other medications. Benralizumab is given as an injection under the skin, usually every 4 to 8 weeks. Patients should discuss with their healthcare provider whether this treatment may be appropriate for their specific condition.

$18,173$18,173 · 2 hospitals

2 hospitals
Cash Price
(No Insurance)
$18,173
Gross Charge
$30,288

No payer-negotiated rates available

Cash Price
(No Insurance)
$18,173
Gross Charge
$30,288

No payer-negotiated rates available

Frequently Asked Questions

How much does Benralizumab 30 mg/ml Syringe cost without insurance?
Cash prices for Benralizumab 30 mg/ml Syringe (CPT J0517) range from $18,173 to $18,173 across 2 hospitals in 1 states. The national average is $18,173.
Which hospital has the cheapest Benralizumab 30 mg/ml Syringe?
Hazard Arh Regional Medical Center has the lowest cash price for Benralizumab 30 mg/ml Syringe at $18,173. The highest price is $18,173 at Harlan Arh Hospital.

Prices shown are sourced from hospital price transparency files published under the Hospital Price Transparency Rule. Actual costs may vary based on your insurance plan, specific clinical circumstances, and additional services required. These prices are not a quote or guarantee.

This site does not provide medical advice. Always consult with your healthcare provider and insurance company before making decisions about medical care. Learn more about our data sources.